Prospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2048-2060
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048
Table 1 Clinicopathological characteristics of the enrolled cohort (n = 151)
Characteristic
Result
Age diagnosis (yr)55.85 ± 13.26
Gender (%)
Male93 (61.6)
Female58 (38.4)
Distance to anal verge (cm) (%)4.91 ± 2.04
> 645 (29.8)
≤ 6106 (70.2)
Pre-CEA (%)
Normal range98 (64.9)
Elevated53 (35.1)
Pre-T (%)
T12 (1.3)
T210 (6.6)
T3133 (88.1)
T46 (4.0)
Pre-N (%)
N038 (25.2)
N+113 (74.8)
Post-T (%)
pT07 (4.6)
pT16 (4.0)
pT248 (31.8)
pT384 (55.6)
pT44 (4.0)
Post-N (%)
pN089 (58.9)
pN+62 (41.1)
Tumor regression grade (%)
Grade 09 (6.3)
Grade 134 (23.9)
Grade 242 (29.6)
Grade 357 (40.1)
HER2 (%)
-124 (82.1)
+27 (17.9)
LVI (%)
+20 (13.2)
-131 (86.8)
Median follow-up period134
Distant metastasis, number (%)
Yes60 (39.7)
No91 (60.3)
Local recurrence, number (%)
Yes24 (15.9)
No127 (84.1)